This page includes news and video on therapies for cardiovascular disease. The therapies covered including drug therapies, cardiovascular surgery, minimally invasive interventional cardiology procedures, electrophysiology (EP) ablation, cardioversion and device therapy.

Large study finds high rates of nonadherence to statin recommendations; women especially averse

Many patients who would clearly benefit by lowered LDL cholesterol levels are choosing to forgo first-time recommendations for statin regimens, according to a population-level study. 

March 3, 2023
Intravascular lithotripsy (IVL) Shockwave Medical PCI PAD CAD trial prsented at SCAI 2022. #DisruptPAD, #DisruptCAD, #SCAI #SCAI22 #SCAI2022

Is IVL equally effective in male and female patients? Shockwave Medical aims to find out with a historic new study

Shockwave announced at TCT 2022 that it hopes to enroll up to 400 patients for a new all-female clinical trial.

September 22, 2022

“We need an answer now”: Cardiologist awarded $2.3M to study cannabis use and heart health in people living with HIV

The four-year analysis will use cardiac MRI scans to closely monitor the heart health of people living with HIV who regularly use cannabis to treat their symptoms. 

July 6, 2022

Catheter-directed thrombolysis boosts survival rates for submassive pulmonary embolism

The new meta-analysis included data from nearly 10,000 patients. 

June 30, 2022
Medtronic and GE Healthcare have received FDA clearance and CE mark approval for a new collaboration designed to improve patient monitoring. The combined solution involves the integration of Medtronic’s INVOS regional oximetry and Microstream capnography technologies into GE Healthcare’s CARESCAPE precision monitoring platform.

Medtronic, GE Healthcare join forces on new-look continuous monitoring solution

The collaboration is aimed at improving patient outcomes after cardiac surgeries and other procedures. 

June 2, 2022

Around the web

Surgeons at NYU Langone Health successfully transplanted two genetically engineered pigs hearts into recently deceased humans in June and July.

Machine learning is playing a key role in predicting all major forms of drug cardiotoxicity, potentially helping reduce late-stage clinical trial failures.

Heart attack patients aged 65 and up stay hospitalized longer than those aged 65 or under—yet the seniors ring up significantly smaller bills per stay. The bad news is that the “savings” likely come in the form of fewer percutaneous coronary interventions (PCIs, aka angioplasties) to open blocked heart arteries nonsurgically.

Trimed Popup
Trimed Popup